GLP-1 agonists have been clinically proven to support sustained weight loss and improve overall health for people struggling with their weight
I mean, the stock surged nearly 15% and added $1.4 billion in market cap because the deal signalled legitimacy and a realistic path to diversify away from compounded semaglutide
This is a smart way to look at it
Applicable Procedures Codes: 32701, 61796, 61797, 61798, 61799, 61800, 63620, 63621, 77301, 77371, 77372, 77373, 77432, 77435, G0339, G0340, G0563
Bergknut N, Meij BP, Hagman R, de Nies KS, Rutges JP, Smolders LA, Creemers LB, Lagerstedt AS, Hazewinkel HA, Grinwis GC: Intervertebral disc disease in dogs - part 1: a new histological grading scheme for classification of intervertebral disc degeneration in dogs